Table 4 Serum concentrations of discriminant analytes and variable importance in projection (VIP) values in participants with and without sarcopenia
variables | Nonsarcopenia | Sarcopenia | VIP | t/Z | P value |
|---|---|---|---|---|---|
(n = 181) | (n = 65) | ||||
LPC16:0 | 117.27(88.63,142.54) | 105.16(85.23,129.62) | 3.896 | -1.543 | 0.123 |
LPC18:2 | 28.67(19.88,36.35) | 24.6(18,34.32) | 2.681 | -1.631 | 0.103 |
LPC18:0 | 36.78(30.52,42.05) | 36.01(30.56,43.05) | 1.077 | 0.204 | 0.839 |
Glycine | 38.66(32.64,48.82) | 39.31(35.04,43.34) | 0.966 | 0.0580 | 0.954 |
Alanine | 49.19(41.52,57.65) | 49.54(42.41,57.35) | 0.825 | 0.053 | 0.958 |
Valine | 40.07(34.88,44.54) | 38.19(33.88,42.16) | 0.820 | -1.566 | 0.1174 |
Phenylalanine | 18.71(16.48,21.84) | 19.09(17.01,22.67) | 0.728 | 1.011 | 0.312 |
Tryptophan | 16.8(14.88,19.15) | 16.16(14.64,18.35) | 0.688 | -1.530 | 0.126 |
Glutamine | 25.32(20.28,30.74) | 26.75(20.64,29.74) | 0.683 | -0.380 | 0.704 |
LPC18:1 | 17.5(14.87,20.82) | 16.91(14.73,20.19) | 0.645 | -0.607 | 0.544 |
Glutamate | 21.93(19.23,24.89) | 20.97(17.09,24.14) | 0.543 | -1.608 | 0.108 |
Leucine | 25.54(22.41,28.9) | 25.43(21.24,27.66) | 0.504 | -1.059 | 0.290 |
C2 | 2.16(1.69,2.58) | 2.05(1.61,2.59) | 0.496 | -0.775 | 0.439 |
Carnitine | 10.04(8.99,11.61) | 10.03(8.5,11.91) | 0.484 | -0.536 | 0.592 |
Ileucine | 12.67(10.96,14.59) | 11.91(10.31,13.99) | 0.347 | -1.708 | 0.088 |
TMAO | 0.43(0.28,0.66) | 0.42(0.27,0.67) | 0.325 | -0.501 | 0.616 |
Betaine | 7.78(6.46,9.13) | 8.12(6.25,9.17) | 0.173 | 0.109 | 0.913 |
C5 | 0.03(0.02,0.03) | 0.02(0.02,0.03) | 0.059 | -2.266 | 0.023 |
C18:1- | 0.1(0.08,0.11) | 0.09(0.08,0.11) | 0.049 | -0.829 | 0.407 |
C10:1 | 0.13(0.1,0.17) | 0.13(0.1,0.19) | 0.041 | 0.357 | 0.721 |